10:37

GLP-1 drugs like semaglutide and tirzepatide work across many conditions because they reduce inflammation, improve insulin sensitivity, and affect blood vessels and immune cells. Approvals are expanding to kidney disease and sleep apnea, but injectable doses run 10 to 15 times higher than natural levels, causing GI problems, possible muscle loss, and rare thyroid tumors in animal studies.

Questions this video answers

Approximately 10–15× the normal physiological dose when given as an injectable.

About 80 percent.

About 19 percent.

Chapters

More from Aaron

53:04
youtube.com

Too Many Gut Fixes Can Undo Your Healing. What Helps It Last | Dr. Sabine Hazan

3d ago
6:54
youtube.com

Sometimes I Treat It Before I Know What Caused It

6d ago
45:33
youtube.com

Your Gut Keeps Its Own Age, and It Can Get Younger

1w ago
6:53
youtube.com

Lyme Is Supposed to Be Diagnosed Without a Blood Test

1w ago
1:18
youtube.com

Women’s Heart Attack Symptoms Differ From Men’s 95% of the Time — Only 30% Have Chest Pain #shorts

2w ago
1:42
youtube.com

Heart Disease Kills More Women Than All Cancers Combined — 80% of Cardiac Research Is on Men #shorts

2w ago
2:03
youtube.com

Women’s Physiology Was Systematically Ignored in Drug Research — The Consequences Are Still #shorts

2w ago
1:03:14
youtube.com

Why Cancer Comes Back Somewhere Else with Dr. Nasha Winters

2w ago
7:10
youtube.com

How Mold Became Too Common to Take Seriously

2w ago
2:37
youtube.com

It Took the FDA 20 Years to Realize Women Need Half the Dose of Ambien #shorts

3w ago
1:32
youtube.com

Until 1993, Women Were Banned From Clinical Drug Trials — Then Those Drugs Were Prescribed t #shorts

3w ago
See all content